RecruitingPhase 1NCT06857890

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers

An Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of the Drug Grammidin With Anesthetic, a Metered Dose Topical Spray Following Single Administration in Healthy Volunteers


Sponsor

Valenta Pharm JSC

Enrollment

24 participants

Start Date

Dec 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the safety, tolerability, and pharmacokinetic profile of the Grammidin with anesthetic, a metered dose topical spray, compared to Grammidin with anesthetic neo, lozenges following single administration in healthy volunteers.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Grammidin with anesthetic neo and a drug called Grammidin with anesthetic, a metered dose topical spray for people with pharyngitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGrammidin with anesthetic neo

Grammidin with anesthetic neo, lozenges, 1 lozenge to be taken once under fed conditions.

DRUGGrammidin with anesthetic, a metered dose topical spray

Grammidin with anesthetic, a metered dose topical spray, 4 sprays to be taken once under fed conditions


Locations(1)

Separate Medical Unit "CoMed" (LLC "Ligand Research")

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06857890


Related Trials